Orchard Therapeutics PLC - ESG Rating & Company Profile powered by AI
This ESG score for Orchard Therapeutics PLC represents the company's transparency towards the UN SDGs. Alternative companies in the scoring peer group for Orchard Therapeutics PLC are displayed. The ESG score covers 17 United Nations Sustainable Development Goals including: 'No Poverty', 'Climate Action' and 'Partnerships for the Goals'.
Orchard Therapeutics PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Orchard Therapeutics PLC | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Orchard Therapeutics PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Orchard Therapeutics PLC report the average age of the workforce?
Sign up for free to unlockDoes Orchard Therapeutics PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Orchard Therapeutics PLC offer flexible work?
Sign up for free to unlockDoes Orchard Therapeutics PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Orchard Therapeutics PLC conduct supply chain audits?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Orchard Therapeutics PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose water use targets?
Sign up for free to unlockDoes Orchard Therapeutics PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Orchard Therapeutics PLC have a product recall in the last two years?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Orchard Therapeutics PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Orchard Therapeutics PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose parental leave metrics?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Orchard Therapeutics PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Orchard Therapeutics PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Orchard Therapeutics PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose its waste policy?
Sign up for free to unlockDoes Orchard Therapeutics PLC report according to TCFD requirements?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose energy use targets?
Sign up for free to unlockDoes Orchard Therapeutics PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Orchard Therapeutics PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Orchard Therapeutics PLC
These potential risks are based on the size, segment and geographies of the company.
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the treatment of adenosine deaminase-severe combined immunodeficiency (ADA-SCID). The company's clinical development products comprise OTL-101 for the treatment of ADA-SCID; OTL-200 to treat metachromatic leukodystrophy; OTL-103 for the treatment of Wiskott-Aldrich syndrome; OTL-102 for X-linked chronic granulomatous disease; and OTL-300 for transfusion-dependent beta-thalassemia. Its preclinical programs include OTL-203 for mucopolysaccharidosis type I, OTL-201 for mucopolysaccharidosis type MPS-IIIA, and OTL-202 for mucopolysaccharidosis type IIIB. It has a strategic collaboration agreement with Pharming Group N.V. for research, development, manufacturing, and commercialization of OTL-105, an investigational ex vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom.